Beyond de novo synthesis in the endoplasmic reticulum, cancer cells augment exogenous uptake via the LDL receptor (LDLR) and scavenger receptor SR-B1 to acquire LDL and HDL cholesterol, respectively (41). Here, LDLR is linked to cancer.